Online citations, reference lists, and bibliographies.
← Back to Search

High-pressure Intrapleural Chemotherapy: Feasibility In The Pig Model

O. Facy, P. Pagès, P. Ortega-Deballon, G. Magnin, S. Ladoire, Bernard Royer, B. Chauffert, A. Bernard
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
BackgroundThe usual treatments for pleural malignancies are mostly palliative. In contrast, peritoneal malignancies are often treated with a curative intent by cytoreductive surgery and intraperitoneal chemotherapy. As pressure has been shown to increase antitumor efficacy, we applied the concept of high-pressure intracavitary chemotherapy to the pleural space in a swine model.MethodsCisplatin and gemcitabine were selected because of their antineoplasic efficacy in vitro in a wide spectrum of cancer cell lines. The pleural cavity of 21 pigs was filled with saline solution; haemodynamic and respiratory parameters were monitored. The pressure was increased to 15-25 cm H2O. This treatment was associated with pneumonectomy in 6 pigs. Five pigs were treated with chemotherapy under pressure.ResultsThe combination of gemcitabine (100 mg/l) and cisplatin (30 mg/l) was highly cytotoxic in vitro. The maximum tolerated pressure was 20 cm H20, due to haemodynamic failure. Pneumonectomy was not tolerated, either before or after pleural infusion. Five pigs survived intrapleural chemotherapy associating gemcitabine and cisplatin with 20 cm H2O pressure for 60 min.ConclusionsHigh-pressure intrapleural chemotherapy is feasible in pigs. Further experiments will establish the pharmacokinetics and determine whether the benefit already shown in the peritoneum is also obtained in the pleura.
This paper references
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration.
P. Jacquet (1996)
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
A. Martin-Ucar (2007)
The pathophysiology of tension pneumothorax in ventilated swine.
E. Barton (1997)
Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
E. de Bree (2002)
Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Y. Ohta (2006)
A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin
K. Speeten (2008)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
V. Verwaal (2003)
Hypoxic Single-Pass Isolated Hepatic Perfusion of Hypotonic Cisplatin: Safety Study in the Pig
P. Ortega-Deballon (2009)
PH: Peritoneal-plasma barrier
P Jacquet (1996)
Tidal volume reduction in patients with acute lung injury when plateau pressures are not high.
F. Jardin (2006)
Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
G. Los (1990)
A phase I feasibility and pharmocokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions
R. Perng (1997)
Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.
R. Blanco (2008)
Zoledronic acid is effective against experimental malignant pleural effusion.
G. Stathopoulos (2008)
High interstitial fluid pressure — an obstacle in cancer therapy
C. Heldin (2004)
Extracorporeal lung membrane provides better lung protection than conventional treatment for severe postpneumonectomy noncardiogenic acute respiratory distress syndrome.
M. Iglesias (2008)
Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
R. Dedrick (1978)
High Intra-abdominal Pressure Enhances the Penetration and Antitumor Effect of Intraperitoneal Cisplatin on Experimental Peritoneal Carcinomatosis
P. Esquis (2006)
Tension pneumothorax—time for a re-think?
S. Leigh-Smith (2004)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
O. Glehen (2004)
Rat P: Which method to deliver heated intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques
P Ortega-Deballon (2010)
Intracavitary therapies for mesothelioma
C. Verschraegen (2001)
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
D. Lardinois (2006)
Development of a sensitive and selective LC-MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma.
Chester L. Bowen (2009)
Drug-related chromosomal changes in chemoresistant human ovarian carcinoma cells.
J. R. Teyssier (1989)
Peritoneal-plasma barrier.
P. Jacquet (1996)
Innovative therapies: intraoperative intracavitary chemotherapy.
M. Chang (2004)
Which Method to Deliver Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin? An Experimental Comparison of Open and Closed Techniques
P. Ortega-Deballon (2010)
Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
I. Opitz (2007)
Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatment
G. Los (2004)
: final results of a phase II study
I Opitz (2008)
postpneumonectomy noncardiogenic acute respiratory distress syndrome

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar